Viewing StudyNCT05966584



Ignite Creation Date: 2024-05-06 @ 7:19 PM
Last Modification Date: 2024-10-26 @ 3:04 PM
Study NCT ID: NCT05966584
Status: TERMINATED
Last Update Posted: 2023-12-22
First Post: 2023-07-20

Brief Title: A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
22-276 View
Alpelisib View
Benralizumab View
Metastatic HR-positive View
HER2-negative breast cancer View
Rash View